<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03792191</url>
  </required_header>
  <id_info>
    <org_study_id>MD.18.02.29</org_study_id>
    <nct_id>NCT03792191</nct_id>
  </id_info>
  <brief_title>Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery</brief_title>
  <official_title>Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will compare between preprocedural ultrasonography and the conventional palpation&#xD;
      technique for spinal anesthesia in obese parturients undergoing elective cesarean delivery&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, controlled, double-blind study will be conducted on ASA physical status&#xD;
      II-III obese parturients with full-term singleton pregnancy undergoing elective cesarean&#xD;
      delivery under spinal anesthesia. The study subjects will be assigned to 2 equal groups. In&#xD;
      the ultrasonography group, lumbar spinal ultrasonography will be performed before&#xD;
      administration of spinal anesthesia. In the palpation group, conventional palpation of the&#xD;
      anatomical landmarks will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 16, 2019</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Needle Passes Required to Obtain Free Cerebrospinal Fluid Flow</measure>
    <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
    <description>Needle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Skin Punctures Required to Obtain Free Cerebrospinal Fluid Flow</measure>
    <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
    <description>Skin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle Pass</measure>
    <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
    <description>Needle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin Puncture</measure>
    <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
    <description>Skin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of the Spinal Procedure</measure>
    <time_frame>Assessed from enrollment in the study until completion of cesarean delivery</time_frame>
    <description>The duration from starting the first skin puncture by the spinal needle to obtaining free CSF flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>Assessed at 1 minute after intrathecal injection</time_frame>
    <description>Patient satisfaction from the procedure assessed immediately after intrathecal injection using a 5-point scale (1 = very unsatisfied; 2 = unsatisfied; 3 = fair; 4 = satisfied; and 5 = very satisfied).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Vascular Puncture</measure>
    <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
    <description>Number of participants with unintentional vascular puncture by the needle during performing the spinal procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Paresthesia</measure>
    <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
    <description>Number of participants with paresthesia reported by the subjects during performing the spinal procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Failure to Obtain Free Cerebrospinal Fluid Flow</measure>
    <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
    <description>Number of participants with failure to obtain free cerebrospinal fluid flow after adequate needle passes at 6 separate skin punctures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Failed Spinal Block</measure>
    <time_frame>Assessed up to 20 minutes after intrathecal injection</time_frame>
    <description>Number of participants with failed spinal block defined as an upper sensory level below T6 assessed by pinprick.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Anesthesia, Spinal</condition>
  <condition>Cesarean Section</condition>
  <condition>Spinal Ultrasound</condition>
  <arm_group>
    <arm_group_label>Ultrasonography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia will be administered with injection of intrathecal bupivacaine and intrathecal fentanyl.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking.Spinal anesthesia will be administered with injection of intrathecal bupivacaine and intrathecal fentanyl.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Lumbar Spinal Ultrasonography</intervention_name>
    <description>Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the intervertebral space with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 intervertebral spaces.</description>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Sham Ultrasound Procedure</intervention_name>
    <description>Moving the ultrasound probe on the patient's back with the machine in the freeze position.</description>
    <arm_group_label>Palpation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Landmark Palpation</intervention_name>
    <description>Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) is assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest intervertebral space. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 intervertebral spaces.</description>
    <arm_group_label>Palpation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal Anesthesia</intervention_name>
    <description>Spinal anesthesia using a 25- or 22-gauge spinal needle</description>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal Bupivacaine</intervention_name>
    <description>Bupivacaine 12.5 mg (2.5 mL 0.5%) will be administered in the subarachnoid space</description>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal Fentanyl</intervention_name>
    <description>Fentanyl 15 μg will be administered in the subarachnoid space</description>
    <arm_group_label>Palpation</arm_group_label>
    <arm_group_label>Ultrasonography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status II-III parturients&#xD;
&#xD;
          -  Full term singleton pregnancy&#xD;
&#xD;
          -  Body mass index ≥ 35 Kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 19 years&#xD;
&#xD;
          -  Women presenting in labor&#xD;
&#xD;
          -  Contraindications to neuraxial anesthesia (Coagulopathy, increased intracranial&#xD;
             pressure, or local skin infection)&#xD;
&#xD;
          -  Significant spinal deformities or previous spinal surgery&#xD;
&#xD;
          -  Preeclampsia&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed M Tawfik, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mansoura University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed A Tolba, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesia, Mansoura University Hospitals</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 1, 2019</study_first_submitted>
  <study_first_submitted_qc>January 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2019</study_first_posted>
  <results_first_submitted>April 23, 2021</results_first_submitted>
  <results_first_submitted_qc>May 20, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 24, 2021</results_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Mohamed Tawfik</investigator_full_name>
    <investigator_title>Lecturer, Department of anesthesia and surgical intensive care, Primary investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 31, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT03792191/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ultrasonography</title>
          <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
        </group>
        <group group_id="P2">
          <title>Palpation</title>
          <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Sliding the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="140"/>
                <participants group_id="P2" count="140"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="140"/>
                <participants group_id="P2" count="140"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ultrasonography</title>
          <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
        </group>
        <group group_id="B2">
          <title>Palpation</title>
          <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Sliding the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="140"/>
            <count group_id="B2" value="140"/>
            <count group_id="B3" value="280"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.2" spread="5.9"/>
                    <measurement group_id="B2" value="30.3" spread="5.5"/>
                    <measurement group_id="B3" value="30.3" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="280"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Egypt</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="280"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159.5" spread="6.1"/>
                    <measurement group_id="B2" value="160" spread="6.1"/>
                    <measurement group_id="B3" value="159.7" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="102" lower_limit="80" upper_limit="160"/>
                    <measurement group_id="B2" value="103" lower_limit="76" upper_limit="140"/>
                    <measurement group_id="B3" value="102" lower_limit="76" upper_limit="160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.2" lower_limit="35.2" upper_limit="61"/>
                    <measurement group_id="B2" value="39.2" lower_limit="35" upper_limit="58.3"/>
                    <measurement group_id="B3" value="39.8" lower_limit="35" upper_limit="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gestational age (weeks)</title>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38" lower_limit="37" upper_limit="41"/>
                    <measurement group_id="B2" value="38" lower_limit="37" upper_limit="40"/>
                    <measurement group_id="B3" value="38" lower_limit="37" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nulliparous</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ease of landmark palpation</title>
          <description>A 4-point scale (1 = the spinous processes and the interspaces can be identified by light palpation; 2 = the spinous processes and the interspaces can be identified by deep palpation; 3 = the spinous processes only can be identified by deep palpation, and the interspaces cannot be identified; 4 = neither the spinous processes nor the interspaces can be identified).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="140"/>
                    <count group_id="B2" value="140"/>
                    <count group_id="B3" value="280"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="119"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="117"/>
                  </measurement_list>
                </category>
                <category>
                  <title>4</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Needle Passes Required to Obtain Free Cerebrospinal Fluid Flow</title>
        <description>Needle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.</description>
        <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Needle Passes Required to Obtain Free Cerebrospinal Fluid Flow</title>
          <description>Needle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.</description>
          <units>needle passes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="1" upper_limit="34"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.62</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>0.00007</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.00005</ci_lower_limit>
            <ci_upper_limit>1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Skin Punctures Required to Obtain Free Cerebrospinal Fluid Flow</title>
        <description>Skin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.</description>
        <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Skin Punctures Required to Obtain Free Cerebrospinal Fluid Flow</title>
          <description>Skin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.</description>
          <units>skin punctures</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="6"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.58</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle Pass</title>
        <description>Needle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.</description>
        <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Needle Pass</title>
          <description>Needle pass is any forward introduction of the spinal needle after its complete or incomplete withdrawal, including the first attempt.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6</p_value>
            <method>Chi-squared, Corrected</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.036</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.15</ci_lower_limit>
            <ci_upper_limit>0.079</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin Puncture</title>
        <description>Skin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.</description>
        <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Successful Obtaining of Free Cerebrospinal Fluid Flow at the First Skin Puncture</title>
          <description>Skin puncture is any separate skin puncture by the spinal needle after its complete withdrawal, including the first attempt.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="108"/>
                    <measurement group_id="O2" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.77</p_value>
            <method>Chi-squared, Corrected</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.021</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.125</ci_lower_limit>
            <ci_upper_limit>0.082</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of the Spinal Procedure</title>
        <description>The duration from starting the first skin puncture by the spinal needle to obtaining free CSF flow</description>
        <time_frame>Assessed from enrollment in the study until completion of cesarean delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of the Spinal Procedure</title>
          <description>The duration from starting the first skin puncture by the spinal needle to obtaining free CSF flow</description>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76" lower_limit="26" upper_limit="734"/>
                    <measurement group_id="O2" value="59" lower_limit="19" upper_limit="700"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.077</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1</ci_lower_limit>
            <ci_upper_limit>20</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>Patient satisfaction from the procedure assessed immediately after intrathecal injection using a 5-point scale (1 = very unsatisfied; 2 = unsatisfied; 3 = fair; 4 = satisfied; and 5 = very satisfied).</description>
        <time_frame>Assessed at 1 minute after intrathecal injection</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>Patient satisfaction from the procedure assessed immediately after intrathecal injection using a 5-point scale (1 = very unsatisfied; 2 = unsatisfied; 3 = fair; 4 = satisfied; and 5 = very satisfied).</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="1" upper_limit="5"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.1</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>0.00003</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.00001</ci_lower_limit>
            <ci_upper_limit>0.00003</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Vascular Puncture</title>
        <description>Number of participants with unintentional vascular puncture by the needle during performing the spinal procedure</description>
        <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Vascular Puncture</title>
          <description>Number of participants with unintentional vascular puncture by the needle during performing the spinal procedure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.99</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Paresthesia</title>
        <description>Number of participants with paresthesia reported by the subjects during performing the spinal procedure</description>
        <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Paresthesia</title>
          <description>Number of participants with paresthesia reported by the subjects during performing the spinal procedure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.99</p_value>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Failure to Obtain Free Cerebrospinal Fluid Flow</title>
        <description>Number of participants with failure to obtain free cerebrospinal fluid flow after adequate needle passes at 6 separate skin punctures.</description>
        <time_frame>Assessed from starting the first attempt of spinal anesthesia until successful administration of spinal anesthesia, an average of 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Failure to Obtain Free Cerebrospinal Fluid Flow</title>
          <description>Number of participants with failure to obtain free cerebrospinal fluid flow after adequate needle passes at 6 separate skin punctures.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Failed Spinal Block</title>
        <description>Number of participants with failed spinal block defined as an upper sensory level below T6 assessed by pinprick.</description>
        <time_frame>Assessed up to 20 minutes after intrathecal injection</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasonography</title>
            <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
          <group group_id="O2">
            <title>Palpation</title>
            <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Failed Spinal Block</title>
          <description>Number of participants with failed spinal block defined as an upper sensory level below T6 assessed by pinprick.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.99</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From enrollment in the study until home discharge, up to 48 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Ultrasonography</title>
          <description>Preprocedural lumbar spinal ultrasonography and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Lumbar Spinal Ultrasonography: Ultrasonography of the lumbar spines using an 8-2 MHz curved array transducer. Identification of the interspace with the best image. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
        </group>
        <group group_id="E2">
          <title>Palpation</title>
          <description>Sham ultrasound procedure. Conventional landmark palpation and skin marking. Spinal anesthesia was administered with injection of intrathecal bupivacaine and intrathecal fentanyl.&#xD;
Sham Ultrasound Procedure: Moving the ultrasound probe on the patient's back with the machine in the freeze position.&#xD;
Conventional Landmark Palpation: Conventional palpation of the anatomical landmarks. The line crossing the iliac crests (Tuffier line) was assumed to cross the spine at L4 spinous process or L3-L4 intervertebral space. Identification of the widest interspace. Marking the patient's skin with horizontal and vertical lines over the L3-L4 and L2-L3 interspaces.&#xD;
Spinal Anesthesia: Spinal anesthesia using a 25- or 22-gauge spinal needle&#xD;
Intrathecal Bupivacaine: Bupivacaine 12.5 mg (2.5 mL 0.5%) was administered in the subarachnoid space&#xD;
Intrathecal Fentanyl: Fentanyl 15 μg was administered in the subarachnoid space</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="140"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="140"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="140"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Mohamed Mohamed Tawfik</name_or_title>
      <organization>Mansoura University</organization>
      <phone>1001183400 ext 0020</phone>
      <email>m2tawfik@mans.edu.eg</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

